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ABSTRACT 
~n order to investigate the role of the stimu~ation of ceU division for the initiation 
(and possi:bly promotion) of live·r tumors by chemical carcinogens, the incor-
poration of radiolabeUed thymidine into liver DNA was dete:rmined in male 
rats. Single doses of various level!s of af.latoxin 81, benzidine and carbon 
tetrachloride (aU known to be genotoxic via DNA binding} did not affect cell 
division, whereas several hepatoca:rcinogens known not to bind to DNA (alpha-
HCH, dofibrate, and 2,3;7,8-t!etrachlorodiibenzo~p~dioxin) gave rise to a dose-
dependent stimulation of Ii ver DNA synthesis within 24 h. An equation combin-
ing the infl.uences of mitotic stimu:lation, expressed as dose required to double 
the contro~ Ievei of DNA synthesis, and DNA binding potency, exp:ressed as t.he 
Covalent Binding Index, correliated weil with the cardnogenk potency for both 
dasses of hepatocardnogens. 
I;NTRODUCTfON 
The daily dose required to induce a given 
percent tumor incid,ence in a rodent life-tim.e 
hioassay on carcinogenicity can vary about 
ten m.illion-fold. Despite this wide range of 
potencies, short-tern1 tests on carcinogenicity 
in general are evaluat.ed on1y in a qualitative 
way, and therefore provide only a yes or no 
answer. · 
Every test gives rise to false positive and 
false negative results because lt detects only 
one step out of a sequence of events ulti-
mately leading to a tumor. A cornbination of 
various short-term tests is therefore bound to 
generate more a nd more false positive results 
so that, ad absurdum, allchemieals will pro-
duce one positive result if a large enough 
battery of tests is used. Faced with the con~ 
servative policy of regulatory ctgendes, the 
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fear of producing a false positive resuh might 
be one reason for so.me reluctance to perform 
more than the minimu1n number of short-
term tests. 
From a theoretical point of view, this ap-
proach is highly unsatisfactory; obviously, 
the more that is known about a chen1ical, the 
more r·eliable is its toxicologic evaluation. 
This prob~em could ibe solved if the short-
term data \'Vere analysed in a quantitative 
manner. Ames and coworkers (1) first calcu-
lated the nurober of Salmonella revertants 
per nmol test substance on the plate. This 
forn1ed the basis for some preliminary a.t-
tempts to correlate carcinogenic and muta-
genic potencies (2) .. Subsequent analyses re-
vealed that the correlation was very weak 
(3), producing a wave of criticism agairrst all 
subsequent attempts to correlate potencies 
obtained from carcinogenicity bioassays with 
the results of short-term tests. 
For some time we have been investigating 
the use of data on covalent binding of chem-
ieals to DNA in vivo to estimate carcinogenic 
potency, and have defined a Covalent Bind-
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ing Index, (CBI) = (p.mol chemical bound per 
mol DNA riucleotide)/(mmol chemical a.d-
n1inistered per kg body weight) (4). Da.ta 
available fro:m the literature and from our 
laboratory have been co1npiled in a revievv 
where it was shown that a semi-quantitative 
correlation between CBI and carcinogenic po-
tency for hepatocarcinogens existed (5), Ex-
tension of the correlaHon to include argans 
other than the liver, and the use of carcino-
genic potencies published as the daily dose 
required to induce a tumor in 50 pHrcent of 
th~e animals treated for the:ilr life span (TD50 
values) revealed an astonishing]y good cor-
relation (6). Although the compounds used 
for that correlation were not intentionally 
selected, an inh~erent selection was still ob-
vious because practically all compounds for 
which the necessary CBI data were available 
possessed structural characteristics which 
made them prone tobe metaboHzed to che'm·-
ically reactive derivatives. Only lately have 
DNA-binding assays been performed on a 
number of Iiver tumor-inducing agents 
where; to a detection limit of CBI < 0.1, no 
DNA binding was detectable [7., 8, 9). A 
graphical representation of the new situat.ion 
is given in Figure 1. H is obvious that the 
correlation has been weakened by the values 
in the lower right hand corner. The com-
pounds on the bottom, there.fore, are tumor-
inducing agents of various potencies vvhose 
mode of action is not related to DNA binding. 
The diagonal is occupied by those carcino-
gens with a mechanisrn of action character-
ized by DNA binding. The intermediate po~ 
sitions are filled by those compounds with 
carcinogenidty due to the combined effects 
of DNA binding arid som,e type of cocarcino· 
genic or promoting activity. 
\1\'ith respect to the use of the CBI as a 
predictive measure :for carcinogenic potency, 
this means that compounds '"rith high CBI 
values are most likely strong cardnogens, 
wh~reas compounds with a CBI < 0.1 are not 
necessarily non-carcinogenic or only weakly 
carcinogenic. 
The question now arises as to whether the 
carcinogens sho·vvn not to bind to DNA ex-
hibit some type ofcommon biologic;.al activity 
which could be assessed in a quantitative 
manner on a short-term basis. Among the 
n1any aspects discussed, the importance of 
cell division is often mentioned: firstly, to fix 
any promutagenic DNA lesion as a heritable 
mutation and thereby potentially initiate cell 
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transforroation, and secondly, to provide 
son1e type of selective pressure during the 
lang period of tumor promotion and progres-
sion. A r,efined experimental system to study 
the influence of chemieals on liver cell divi-
sion in the rat has been used by Schulte-
Hermann and coworlkers (10). Their efforts 
were directed primarily towards an elucida-
tion of the n1echanisn1 of cell transforn1ation; 
we no\N tried to use their experimental set-
up to con1pare the ability of different hepa-
tocarcinogens to stünulate DNA synthesis in 
rat Hver. The value we searched for was the 
dose that vvas requir·ed to double the DNA 
synthesis rate within 24 hours (DD). Three 
dose levels were chosen for each hepatocar-
cinogen tested, the highest dose being araund 
the TDso, and the two lower doses were one 
tenth and one hundredth thereof. 
METHODS 
Young adult Sprague-Davvley rats [Iva:SIV-
so.SD] from Ivanovas, Kisslegg FRG~ were 
kept singly in Macrolone cages. The illumi-
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nation tim.e was fron1 5 a1n to 5 p1n. Food 
pellets in unlimited quantity were availa.ble 
only between 5· pm. and 10 p1n, i.e., for five · 
hours after the beginning of the dark phase. 
in order to synchronize Hver cell division and 
thereby reduce the diurnal variabilüy be-
tween single anin1als. Drinking vvater \Nas 
available at all times. After at least two weeks 
of acclimatization to the restricted dietary 
regimen, and ensuring that the body \A.reight 
gain was back to normal, two animals per 
group were given at 4 am one single dose by 
gavage of one of six hepatocarcinogens in 0.5 
ml solution. Three genotoxic agents were 
used: afl.atoxin B1 (AFBt) .in ethanol (10-5 , 
10-4 , 10-3 n1n1ol/kg), benzidine (BZD) in 
ethanol (0.01, 0.1, l n1moljkg), carbon tetra-
chloride (CCI4) in corn o:il (0.01, 0.1, 1 mmol/ 
kg), and three bepatocarcinogens known not 
to bind appreciably to liver DNA: a-hexa-
chlorocyclohexane ((:~-HCH) in corn oil (0.01, 
0.1, 1 mmol/kg), dofibrate (CLF) in corn oil 
(0.01, 0.1, 1 mmol/kg), 2, 3, 7, '8-tetrachloro-
dihenzo-p-dioxin (TCDD) in corn oil (only 
one dose of 10 p.g/kg, about 3 ·10-5 mmol/kg}. 
Four control animals remained untreated. 
Food consun1ption during the following 5~ 
hour feeding period vvas 16 .± 5 g, spanning 
frmn 6.1 g (AFB1 low dose) to 23.1 g (a-HCH 
intermediate dose). At 04.00h the follovving 
morning, i.e., 24 hours after the administra-
tion of the test compound, all anin1als \o\rere 
given 2,uCi/kg fmethyl-14C]thymidine (TdR, 
61 mCi/mmol; o1Jtained from the Radiochem-
ical Centre, Ame:rsharn, EnglCind) by gavage 
in 0:9% aqueous NaCL One rat of the high-
dose group of each compound was placed in 
an all-glass metabolism cage where a flow of 
0.4 L/min transported the ai.r to agas-was hing 
bottle filled \.Vith ethanolamine/methanol, 
1:4, in order to trap the carbon dioxide ex-
pired. Aliquots of this solution were counted 
for (14C]radioactivHy after 1, 2,. and 3 hours 
to check \o\rhether the bioavailability of the 
radiolabelled DNA precursor was more or 
less uniforn1 an1ongst all individual anünals. 
Four hours later, at 08.00h, the animals V\rere 
kHled by an ether overdose, the liver was 
exci.sed and n1inced, and DNA was isolated 
fron1 an aliquot by an abbreviat.ed standard 
procedure (11), essentially by phenol extrac~ 
tion and hydroxylapatite adsorption chro:. 
matography. An aliquot of the DNA: eluted 
from the column with a high ionic strength 
buffer, was counted for radioactivity, and the 
amount of DNA \.Vas assessed on the basis of 
the UV absorbance at 260 nn1, taking an ex-
tinction value of 20 for a solution of 1 mg/ml. 
The specific activ:ity of the DNA ( expressed 
in dpm/mg) was divided by the dose of radio-
activity adnünistered (expressed in dpm/kg 
b.vv.), and this value "''as multiplied by 309 x 
106 in order to convert th·e data to the molar 
units of an incorporation index (Il) = (J:tnlol 
TdR incorporated per mol DNA-nucleotide)/ 
(n1mol TdR adn1inistered per kg body 
weight). 
RESULTS 
Figure 2 sumn1arizes the r.esults obtained. 
It can be seen that none of the three DNA-
binding agents, AFB.,, BZD, nor CC14 stimu-
lated cell division. Rather, there was some 
inhibition by AFB1 over th.e whole dose 
range, and by CC14 or BZD with increasing 
dos.e only. The three hepatocarcinogens 
known not to inte:ract with DNA~ nam.ely 
TCDD, CLF and a-HCH, gave rise to a t.hree 
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'fiG. 2-lncorporation of i[m·ethyl- 14C]thymi-
dine into rat Hver DNA 24 hours after a single 
administration of various dos·es of hepatocardno-
gens. The incorp·oration index is described in the 
Methods Section. All points represent means of 
two animals. The refative error ( 1 standard devia-
tion) averaged over all duplicate determinations 
was 34 percent. The shaded area represents the 
incorporation index derived from 4 control animals 
(2700 ± 1000). lhe interrupted fine is at the Ievei 
of tw:ice the control rate of DNA synthesis. 
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to four fold stimulation of liver DNA synthe-
sis at the highest dose level, and the inter-
mediate dose of CLF and of a-HCH produced 
approximately a doubl:ing of the controllevel 
of DNA synthesis. 
The shaded area covers a range of ± 1 S.D. 
for the control DNA synthesis rates obtained 
from four animals. The variability, therefore, 
was relatively large despite the fact that the 
anima]s had been synch:ronized by a re-
stricted feeding schedule. One part of the 
variabiUty is probably due to different avail~ 
abilities of the radiolabellad DNA pr·ecursor 
thymidine: The 14C02 recoveries in the air 
exhaled by the single animals within 3 hours 
after the oral administration of radiolabelled 
thymidine spanned from 7 to 16 percent of 
the radioact:ilvity administered. Another rea-
son forthelarge variations might have been 
the different food consumpHons before sac-
rifice since a trend correlating food i.ntake 
and DNA synthesis was observed. It will be 
irnportant to investigate this effect in order 
to find out if food uptake alone could be used 
as a measure for the Stimulation of liver DNA 
synthesis. 
The dose required for each compound to 
bring about a doubling of the· liver DNA syn-
thesis (DD}, is shown in Table l. For CLF and 
a-HCH, the intermediate dos·e us.ed \~Yas 
taken for further calculations. For the three 
DNA-binding agents which were inactive at 
all dose levels tested, an extrapolation to~ 
wards high er dose levels had tobe performed 
with the assumption that the dose-response 
shape would. be s:imilar to the one seen with 
CLF and a-HCH. It was therefore assumed 
that aflatoxin would have tobe administered 
in a theoretical dose Ievel three orders of 
magnitude. higher than the highest dose 
tested. For BZD, the points lay in the low 
standard deviat:ion region of the set of control 
experiments; thus a shift of two orders of 
magnitude was assumed, and one step by a 
factor of ten was assum.ed to be required for 
carbon tetrachloride to reach a doubling 
dose. Due to acute toxicity, these extrapo-
lated doses cannot be test,ed with anim.als. 
TableI also summarizes data on hepatocar-
ci.nogenic potency and cqvalent binding to 
rat Hver DNA. The values given in this Table 
do not represent exact values, but rather dif:. 
ferent orders of magnitude. The \lSe of differ-
ent strains and of different experimental pro-
tocols, for instance, can lead to uncertainties 
of ± 2 orders of magnitude within subsets of 
different TD50 values calculated for the same 
carcinogen(12). However, as the carcinogenic 
potency, the CBI, and the dou bling dose for 
the stin1ulation of DNA synthesis span 6 to 7 
orders of magnitude., this low accuracy is, 
neverthelesst sufficient for an evaluation of 
categories of different potencies. 
Fig. 3 shows the correlation of carcinog~nic 
potency with either CBI (top} or Stimulation 
of liver DNA synthesis (DD) (bottom). In each 
representation one group of three hepatocar-
cinogens lies along a diagonal, thereby indi-
cating a good correlaUon between the two 
variables, ·whereas the other group lies on the 
botton1 of the diagram signaHing that the two 
biological endpoints are completely unre-
Iated. A .mathematical ana]vsis of the data 
presented in tbese charts mu~st therefore pro~ 
duce the low correlation coefficients of I r I = 
0.24 or 0.59 for the correlation bet,l\'een TD50 
and CBI or DD. It is, however, promising that 
the compounds which fit with respect to CBI 
do not fit with respect to sti.mulat:ion of DNA 
svnthesis, and vice versa. This clearcut situ-
aÜon presenting two groups of chemieals es-
sentially exhibiting two differ-ent modes of 
carcinogenic activity provides the basis for a 
significant improvement in the prediction of 
carcinogenic potency if the two correlations 
are combined in the general form of: Garci-
nogenie Potency = DNA Binding X Stimula-
tion ofDNA Synthesis; using, a multiple linear 
TABLE ~~Set of Oata Used :in the Correlations of Ca-rcinogenic Potency (TD50) with Covalent DNA 
ß.indiing (CBI) and/or the. Dose Required to Double DiNA Synthesis in Rat Uver (OD) 
Hepato-
carcinogen 
TD5o CBI DD [mmol/kg] 
(mmol/kg/d] [CBI units] Determined Used in Calculations 
----------------------~---~"··--
AFB1 6 X 10-& 
Benzidine 0.07 
CCI4 0.1 
alpha-HCH 0.5 
Clofibrate 1 
TCDD 2 ·10-7 
10000 
200 
50 
0.02 
<0.1 
<0.1 
>>>10-3 
>>1 
>1 
0.1 
0.1 
<3 X 10-;, 
1 
100 
10 
0.1 
0.1 
3 X 10-;; 
'.1 
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FIG. 3-Correlation of ·covalent DNA bi.nding 
(CBI, top) andl stimulation of liver DNA. synthesDs 
(DO, bottom) with cardnog·enic potency for the :Six 
hepatocarcinogens tested. 
regression analysis on the basis of their 1oga-
rithms. The eq uation: 
A) logTD!in =·ao + a.~·logCBI + a2 ·logDD 
can be sol ved v..rlth the six data triplets given 
in Table I. The resulting equation: 
B) logTD5o = -0.6- 1.2·logCBI + 1.5·logDD 
has a high m.ultiple line.ar cor.relation coeffi-
cient of r = 0.98. It follows that a quantitative 
combination of the data obtained from hvo 
short-term~ tests measuring completely differ-
ent biological events might provide a hitherto 
unseen predictive power to evaluate the po-
tency of chemical carcinogens acting on dif~ 
f!erent steps of the cardnogenic process. The 
coefficients a, and a2 in the equation A) are 
of about equal magnitude. This means that 
both DNA binding for the genotoxic carcin-
ogens and fhe stimulation of oell division for 
the other group of carcinogens studied here 
seem to possess similar importance in the 
entire process of tumor induction. 
OtSCUSSii<:)N 
Parodi and coworkers (13) have shovvn that 
the prediction of a carcinogenic potency of a 
chemical carcinogen can be improved if the 
data obta_ined from two (or n1ore) quantifiable 
short-term tests are con1bined. The best im-
provement is found if both tests correlate to 
s'Ome extent with carcinogenicity but poorly 
correlate with one another. This latter re-
quirem.ent is n11et by the combination used 
her,e: DNA binding and stin1ulation of DNA 
synthesis both are important parameters in 
the process oftumor initiation and promotion 
but are very different biological endpoints .. A 
combination should therefor~e yield a sub-
stantial improvement in the attempt to assess 
carcinogenic potency because so far, estab-
lished short-term tests have almest exclu-
sively measured one or the other aspect of 
genotoxicity. 
The data presented in this report are, hO'IN-
ever. highly preliminary and much \t\Tork re-
n1ains tobe done before vve can state that the 
system presented in this report does indeed 
reflect the type of stim.ulation of cell division 
which parallels the fixation of a premuta-
tional DNA lesion or signals so~me type of 
promoting activHy. Caution is necessary be-
cause of the following observations: 
First, the largc inter-individual variabHi-
t1les am.ong control anilnals is a sign that we 
are dealing with a highly fragile equilihrium 
readily disturbed by a number of influences 
not necessarily related to the process of tu-
m.or formation. Among these variables, food 
intake n1ight p!lay an in1po:rtant role. Cytotox-
icity wHh the regenerating processes elicited 
therefrom. must also be controlled. Work by 
Schulte-Hermann on carbon tetrachloride 
showed, for instance, that a stimulation of 
DNA synthesis can be observed, but on1y 48 
h after its admjnistration. ·More work wlll 
have to he directed into stabiHzing the system 
and into investigating the influence of fasting, 
forced feedingj and hepatotoxicity. 
Second, as a plane can be fitted perfectly 
onto any three points, the data base must be 
enlarged beyond six va.lues to prove that the 
positive correlation obtained vvas not due to 
1nere chance. More chemieals will have tobe 
investigated and it will be interesting to de-
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termine i:f ergans other than the liver also 
lend themselves to this type of analysis. 
Thircl, more refinecl dose-response rela-
tionships tnust be establishecl for all chemi-
eals which are found to be positive in the 
broad dose range used here. The slope of the 
close response and its relation to other vari-
ables, such as food consumption or cytotox-
icity, will then be an additional crHerion for 
evaluating the proposed mechanisn1s of he-
patocarcinogens. 
Other preliminary findings, however, 
1nake the system worthy of further investi-
gation: The -y-isomer of HCH, which is not a 
hepatocarcinogen, showed the same low 
DNA binding as a-HCH in the CHI test (9), 
but did not stimulate liver DNA synthesis. 
Thus, the present system vvas able to discrim-
inate biological activities on the basis of rel-
atively subtle stereochemical differences. 
Therefore, there is justified hope that a quan· 
titative assessment of the potency ofchemical 
carcinogens, one of the most important cri-
teria for any risk assessm.ent, will become 
possible on the basis of a combination of 
short-tern1 tests. The choice of the most ap-
propri.ate test battery vvHl be determined by 
the elucidation of the most critical biological 
events which govern the process of chemical 
carcinogenesis. 
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